The global market for Enzalutamide Soft Capsules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Enzalutamide soft capsules are an oral medication used in the treatment of metastatic castration-resistant prostate cancer. Each soft capsule contains the active ingredient enzalutamide, a potent androgen receptor inhibitor that works by inhibiting the action of androgens (such as testosterone) on prostate cancer cells.

North American market for Enzalutamide Soft Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Enzalutamide Soft Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Enzalutamide Soft Capsules include Astellas Pharma, Pfizer, Intas Pharmaceuticals, Aprazer Healthcare Pharma, Arechar Healthcare, Glenmark Pharma, BDR Pharma, Qilu Pharmaceutical, Kelun Pharmaceutical, Yichang Humanwell Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enzalutamide Soft Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzalutamide Soft Capsules.

The Enzalutamide Soft Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Enzalutamide Soft Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Enzalutamide Soft Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Enzalutamide Soft Capsules Market Report

Report Metric	Details
Report Name	Enzalutamide Soft Capsules Market
Segment by Type	Original Drug Generic Drug
Segment by Application	Hospital and Clinic Retail Pharmacies Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Astellas Pharma, Pfizer, Intas Pharmaceuticals, Aprazer Healthcare Pharma, Arechar Healthcare, Glenmark Pharma, BDR Pharma, Qilu Pharmaceutical, Kelun Pharmaceutical, Yichang Humanwell Pharmaceutical, Jiangsu Hansoh Pharmaceutical, PuraCap Pharmaceuticals, Shenyang Hongqi Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enzalutamide Soft Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enzalutamide Soft Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Enzalutamide Soft Capsules Market report?

Ans: The main players in the Enzalutamide Soft Capsules Market are Astellas Pharma, Pfizer, Intas Pharmaceuticals, Aprazer Healthcare Pharma, Arechar Healthcare, Glenmark Pharma, BDR Pharma, Qilu Pharmaceutical, Kelun Pharmaceutical, Yichang Humanwell Pharmaceutical, Jiangsu Hansoh Pharmaceutical, PuraCap Pharmaceuticals, Shenyang Hongqi Pharmaceutical

What are the Application segmentation covered in the Enzalutamide Soft Capsules Market report?

Ans: The Applications covered in the Enzalutamide Soft Capsules Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Enzalutamide Soft Capsules Market report?

Ans: The Types covered in the Enzalutamide Soft Capsules Market report are Original Drug, Generic Drug

1 Enzalutamide Soft Capsules Market Overview

1.1 Product Definition

1.2 Enzalutamide Soft Capsules by Type

1.2.1 Global Enzalutamide Soft Capsules Market Value Comparison by Type (2024 VS 2031)

1.2.2 Original Drug

1.2.3 Generic Drug

1.3 Enzalutamide Soft Capsules by Application

1.3.1 Global Enzalutamide Soft Capsules Market Value by Application (2024 VS 2031)

1.3.2 Hospital and Clinic

1.3.3 Retail Pharmacies

1.3.4 Other

1.4 Global Enzalutamide Soft Capsules Market Size Estimates and Forecasts

1.4.1 Global Enzalutamide Soft Capsules Revenue 2020-2031

1.4.2 Global Enzalutamide Soft Capsules Sales 2020-2031

1.4.3 Global Enzalutamide Soft Capsules Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Enzalutamide Soft Capsules Market Competition by Manufacturers

2.1 Global Enzalutamide Soft Capsules Sales Market Share by Manufacturers (2020-2025)

2.2 Global Enzalutamide Soft Capsules Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Enzalutamide Soft Capsules Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Enzalutamide Soft Capsules, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Enzalutamide Soft Capsules, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Enzalutamide Soft Capsules, Product Type & Application

2.7 Global Key Manufacturers of Enzalutamide Soft Capsules, Date of Enter into This Industry

2.8 Global Enzalutamide Soft Capsules Market Competitive Situation and Trends

2.8.1 Global Enzalutamide Soft Capsules Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Enzalutamide Soft Capsules Players Market Share by Revenue

2.8.3 Global Enzalutamide Soft Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Enzalutamide Soft Capsules Market Scenario by Region

3.1 Global Enzalutamide Soft Capsules Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Enzalutamide Soft Capsules Sales by Region: 2020-2031

3.2.1 Global Enzalutamide Soft Capsules Sales by Region: 2020-2025

3.2.2 Global Enzalutamide Soft Capsules Sales by Region: 2026-2031

3.3 Global Enzalutamide Soft Capsules Revenue by Region: 2020-2031

3.3.1 Global Enzalutamide Soft Capsules Revenue by Region: 2020-2025

3.3.2 Global Enzalutamide Soft Capsules Revenue by Region: 2026-2031

3.4 North America Enzalutamide Soft Capsules Market Facts & Figures by Country

3.4.1 North America Enzalutamide Soft Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Enzalutamide Soft Capsules Sales by Country (2020-2031)

3.4.3 North America Enzalutamide Soft Capsules Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Enzalutamide Soft Capsules Market Facts & Figures by Country

3.5.1 Europe Enzalutamide Soft Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Enzalutamide Soft Capsules Sales by Country (2020-2031)

3.5.3 Europe Enzalutamide Soft Capsules Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Enzalutamide Soft Capsules Market Facts & Figures by Region

3.6.1 Asia Pacific Enzalutamide Soft Capsules Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Enzalutamide Soft Capsules Sales by Region (2020-2031)

3.6.3 Asia Pacific Enzalutamide Soft Capsules Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Enzalutamide Soft Capsules Market Facts & Figures by Country

3.7.1 Latin America Enzalutamide Soft Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Enzalutamide Soft Capsules Sales by Country (2020-2031)

3.7.3 Latin America Enzalutamide Soft Capsules Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Enzalutamide Soft Capsules Market Facts & Figures by Country

3.8.1 Middle East and Africa Enzalutamide Soft Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Enzalutamide Soft Capsules Sales by Country (2020-2031)

3.8.3 Middle East and Africa Enzalutamide Soft Capsules Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Enzalutamide Soft Capsules Sales by Type (2020-2031)

4.1.1 Global Enzalutamide Soft Capsules Sales by Type (2020-2025)

4.1.2 Global Enzalutamide Soft Capsules Sales by Type (2026-2031)

4.1.3 Global Enzalutamide Soft Capsules Sales Market Share by Type (2020-2031)

4.2 Global Enzalutamide Soft Capsules Revenue by Type (2020-2031)

4.2.1 Global Enzalutamide Soft Capsules Revenue by Type (2020-2025)

4.2.2 Global Enzalutamide Soft Capsules Revenue by Type (2026-2031)

4.2.3 Global Enzalutamide Soft Capsules Revenue Market Share by Type (2020-2031)

4.3 Global Enzalutamide Soft Capsules Price by Type (2020-2031)

5 Segment by Application

5.1 Global Enzalutamide Soft Capsules Sales by Application (2020-2031)

5.1.1 Global Enzalutamide Soft Capsules Sales by Application (2020-2025)

5.1.2 Global Enzalutamide Soft Capsules Sales by Application (2026-2031)

5.1.3 Global Enzalutamide Soft Capsules Sales Market Share by Application (2020-2031)

5.2 Global Enzalutamide Soft Capsules Revenue by Application (2020-2031)

5.2.1 Global Enzalutamide Soft Capsules Revenue by Application (2020-2025)

5.2.2 Global Enzalutamide Soft Capsules Revenue by Application (2026-2031)

5.2.3 Global Enzalutamide Soft Capsules Revenue Market Share by Application (2020-2031)

5.3 Global Enzalutamide Soft Capsules Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Astellas Pharma

6.1.1 Astellas Pharma Company Information

6.1.2 Astellas Pharma Description and Business Overview

6.1.3 Astellas Pharma Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Astellas Pharma Enzalutamide Soft Capsules Product Portfolio

6.1.5 Astellas Pharma Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pfizer Enzalutamide Soft Capsules Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Intas Pharmaceuticals

6.3.1 Intas Pharmaceuticals Company Information

6.3.2 Intas Pharmaceuticals Description and Business Overview

6.3.3 Intas Pharmaceuticals Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Intas Pharmaceuticals Enzalutamide Soft Capsules Product Portfolio

6.3.5 Intas Pharmaceuticals Recent Developments/Updates

6.4 Aprazer Healthcare Pharma

6.4.1 Aprazer Healthcare Pharma Company Information

6.4.2 Aprazer Healthcare Pharma Description and Business Overview

6.4.3 Aprazer Healthcare Pharma Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Aprazer Healthcare Pharma Enzalutamide Soft Capsules Product Portfolio

6.4.5 Aprazer Healthcare Pharma Recent Developments/Updates

6.5 Arechar Healthcare

6.5.1 Arechar Healthcare Company Information

6.5.2 Arechar Healthcare Description and Business Overview

6.5.3 Arechar Healthcare Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Arechar Healthcare Enzalutamide Soft Capsules Product Portfolio

6.5.5 Arechar Healthcare Recent Developments/Updates

6.6 Glenmark Pharma

6.6.1 Glenmark Pharma Company Information

6.6.2 Glenmark Pharma Description and Business Overview

6.6.3 Glenmark Pharma Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Glenmark Pharma Enzalutamide Soft Capsules Product Portfolio

6.6.5 Glenmark Pharma Recent Developments/Updates

6.7 BDR Pharma

6.7.1 BDR Pharma Company Information

6.7.2 BDR Pharma Description and Business Overview

6.7.3 BDR Pharma Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2020-2025)

6.7.4 BDR Pharma Enzalutamide Soft Capsules Product Portfolio

6.7.5 BDR Pharma Recent Developments/Updates

6.8 Qilu Pharmaceutical

6.8.1 Qilu Pharmaceutical Company Information

6.8.2 Qilu Pharmaceutical Description and Business Overview

6.8.3 Qilu Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Qilu Pharmaceutical Enzalutamide Soft Capsules Product Portfolio

6.8.5 Qilu Pharmaceutical Recent Developments/Updates

6.9 Kelun Pharmaceutical

6.9.1 Kelun Pharmaceutical Company Information

6.9.2 Kelun Pharmaceutical Description and Business Overview

6.9.3 Kelun Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Kelun Pharmaceutical Enzalutamide Soft Capsules Product Portfolio

6.9.5 Kelun Pharmaceutical Recent Developments/Updates

6.10 Yichang Humanwell Pharmaceutical

6.10.1 Yichang Humanwell Pharmaceutical Company Information

6.10.2 Yichang Humanwell Pharmaceutical Description and Business Overview

6.10.3 Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Product Portfolio

6.10.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates

6.11 Jiangsu Hansoh Pharmaceutical

6.11.1 Jiangsu Hansoh Pharmaceutical Company Information

6.11.2 Jiangsu Hansoh Pharmaceutical Description and Business Overview

6.11.3 Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Product Portfolio

6.11.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates

6.12 PuraCap Pharmaceuticals

6.12.1 PuraCap Pharmaceuticals Company Information

6.12.2 PuraCap Pharmaceuticals Description and Business Overview

6.12.3 PuraCap Pharmaceuticals Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2020-2025)

6.12.4 PuraCap Pharmaceuticals Enzalutamide Soft Capsules Product Portfolio

6.12.5 PuraCap Pharmaceuticals Recent Developments/Updates

6.13 Shenyang Hongqi Pharmaceutical

6.13.1 Shenyang Hongqi Pharmaceutical Company Information

6.13.2 Shenyang Hongqi Pharmaceutical Description and Business Overview

6.13.3 Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Product Portfolio

6.13.5 Shenyang Hongqi Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Enzalutamide Soft Capsules Industry Chain Analysis

7.2 Enzalutamide Soft Capsules Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Enzalutamide Soft Capsules Production Mode & Process Analysis

7.4 Enzalutamide Soft Capsules Sales and Marketing

7.4.1 Enzalutamide Soft Capsules Sales Channels

7.4.2 Enzalutamide Soft Capsules Distributors

7.5 Enzalutamide Soft Capsules Customer Analysis

8 Enzalutamide Soft Capsules Market Dynamics

8.1 Enzalutamide Soft Capsules Industry Trends

8.2 Enzalutamide Soft Capsules Market Drivers

8.3 Enzalutamide Soft Capsules Market Challenges

8.4 Enzalutamide Soft Capsules Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Astellas Pharma

Pfizer Inc

Intas Pharmaceuticals

Aprazer Healthcare Pharma

Yichang Humanwell Pharmaceutical

Jiangsu Hansoh Pharmaceutical

Puracap Pharmaceuticals

Shenyang Hongqi Pharmaceutical

List of Tables

Table 1. Global Enzalutamide Soft Capsules Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Enzalutamide Soft Capsules Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Enzalutamide Soft Capsules Market Competitive Situation by Manufacturers in 2024

Table 4. Global Enzalutamide Soft Capsules Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Enzalutamide Soft Capsules Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Enzalutamide Soft Capsules Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Enzalutamide Soft Capsules Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Enzalutamide Soft Capsules Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Enzalutamide Soft Capsules, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Enzalutamide Soft Capsules, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Enzalutamide Soft Capsules, Product Type & Application

Table 12. Global Key Manufacturers of Enzalutamide Soft Capsules, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Enzalutamide Soft Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzalutamide Soft Capsules as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Enzalutamide Soft Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Enzalutamide Soft Capsules Sales by Region (2020-2025) & (K Units)

Table 18. Global Enzalutamide Soft Capsules Sales Market Share by Region (2020-2025)

Table 19. Global Enzalutamide Soft Capsules Sales by Region (2026-2031) & (K Units)

Table 20. Global Enzalutamide Soft Capsules Sales Market Share by Region (2026-2031)

Table 21. Global Enzalutamide Soft Capsules Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Enzalutamide Soft Capsules Revenue Market Share by Region (2020-2025)

Table 23. Global Enzalutamide Soft Capsules Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Enzalutamide Soft Capsules Revenue Market Share by Region (2026-2031)

Table 25. North America Enzalutamide Soft Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Enzalutamide Soft Capsules Sales by Country (2020-2025) & (K Units)

Table 27. North America Enzalutamide Soft Capsules Sales by Country (2026-2031) & (K Units)

Table 28. North America Enzalutamide Soft Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Enzalutamide Soft Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Enzalutamide Soft Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Enzalutamide Soft Capsules Sales by Country (2020-2025) & (K Units)

Table 32. Europe Enzalutamide Soft Capsules Sales by Country (2026-2031) & (K Units)

Table 33. Europe Enzalutamide Soft Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Enzalutamide Soft Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Enzalutamide Soft Capsules Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Enzalutamide Soft Capsules Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Enzalutamide Soft Capsules Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Enzalutamide Soft Capsules Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Enzalutamide Soft Capsules Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Enzalutamide Soft Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Enzalutamide Soft Capsules Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Enzalutamide Soft Capsules Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Enzalutamide Soft Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Enzalutamide Soft Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Enzalutamide Soft Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Enzalutamide Soft Capsules Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Enzalutamide Soft Capsules Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Enzalutamide Soft Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Enzalutamide Soft Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Enzalutamide Soft Capsules Sales (K Units) by Type (2020-2025)

Table 51. Global Enzalutamide Soft Capsules Sales (K Units) by Type (2026-2031)

Table 52. Global Enzalutamide Soft Capsules Sales Market Share by Type (2020-2025)

Table 53. Global Enzalutamide Soft Capsules Sales Market Share by Type (2026-2031)

Table 54. Global Enzalutamide Soft Capsules Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Enzalutamide Soft Capsules Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Enzalutamide Soft Capsules Revenue Market Share by Type (2020-2025)

Table 57. Global Enzalutamide Soft Capsules Revenue Market Share by Type (2026-2031)

Table 58. Global Enzalutamide Soft Capsules Price (US$/Unit) by Type (2020-2025)

Table 59. Global Enzalutamide Soft Capsules Price (US$/Unit) by Type (2026-2031)

Table 60. Global Enzalutamide Soft Capsules Sales (K Units) by Application (2020-2025)

Table 61. Global Enzalutamide Soft Capsules Sales (K Units) by Application (2026-2031)

Table 62. Global Enzalutamide Soft Capsules Sales Market Share by Application (2020-2025)

Table 63. Global Enzalutamide Soft Capsules Sales Market Share by Application (2026-2031)

Table 64. Global Enzalutamide Soft Capsules Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Enzalutamide Soft Capsules Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Enzalutamide Soft Capsules Revenue Market Share by Application (2020-2025)

Table 67. Global Enzalutamide Soft Capsules Revenue Market Share by Application (2026-2031)

Table 68. Global Enzalutamide Soft Capsules Price (US$/Unit) by Application (2020-2025)

Table 69. Global Enzalutamide Soft Capsules Price (US$/Unit) by Application (2026-2031)

Table 70. Astellas Pharma Company Information

Table 71. Astellas Pharma Description and Business Overview

Table 72. Astellas Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Astellas Pharma Enzalutamide Soft Capsules Product

Table 74. Astellas Pharma Recent Developments/Updates

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Pfizer Enzalutamide Soft Capsules Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Intas Pharmaceuticals Company Information

Table 81. Intas Pharmaceuticals Description and Business Overview

Table 82. Intas Pharmaceuticals Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Intas Pharmaceuticals Enzalutamide Soft Capsules Product

Table 84. Intas Pharmaceuticals Recent Developments/Updates

Table 85. Aprazer Healthcare Pharma Company Information

Table 86. Aprazer Healthcare Pharma Description and Business Overview

Table 87. Aprazer Healthcare Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Aprazer Healthcare Pharma Enzalutamide Soft Capsules Product

Table 89. Aprazer Healthcare Pharma Recent Developments/Updates

Table 90. Arechar Healthcare Company Information

Table 91. Arechar Healthcare Description and Business Overview

Table 92. Arechar Healthcare Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Arechar Healthcare Enzalutamide Soft Capsules Product

Table 94. Arechar Healthcare Recent Developments/Updates

Table 95. Glenmark Pharma Company Information

Table 96. Glenmark Pharma Description and Business Overview

Table 97. Glenmark Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Glenmark Pharma Enzalutamide Soft Capsules Product

Table 99. Glenmark Pharma Recent Developments/Updates

Table 100. BDR Pharma Company Information

Table 101. BDR Pharma Description and Business Overview

Table 102. BDR Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. BDR Pharma Enzalutamide Soft Capsules Product

Table 104. BDR Pharma Recent Developments/Updates

Table 105. Qilu Pharmaceutical Company Information

Table 106. Qilu Pharmaceutical Description and Business Overview

Table 107. Qilu Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Qilu Pharmaceutical Enzalutamide Soft Capsules Product

Table 109. Qilu Pharmaceutical Recent Developments/Updates

Table 110. Kelun Pharmaceutical Company Information

Table 111. Kelun Pharmaceutical Description and Business Overview

Table 112. Kelun Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Kelun Pharmaceutical Enzalutamide Soft Capsules Product

Table 114. Kelun Pharmaceutical Recent Developments/Updates

Table 115. Yichang Humanwell Pharmaceutical Company Information

Table 116. Yichang Humanwell Pharmaceutical Description and Business Overview

Table 117. Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Product

Table 119. Yichang Humanwell Pharmaceutical Recent Developments/Updates

Table 120. Jiangsu Hansoh Pharmaceutical Company Information

Table 121. Jiangsu Hansoh Pharmaceutical Description and Business Overview

Table 122. Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Product

Table 124. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates

Table 125. PuraCap Pharmaceuticals Company Information

Table 126. PuraCap Pharmaceuticals Description and Business Overview

Table 127. PuraCap Pharmaceuticals Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. PuraCap Pharmaceuticals Enzalutamide Soft Capsules Product

Table 129. PuraCap Pharmaceuticals Recent Developments/Updates

Table 130. Shenyang Hongqi Pharmaceutical Company Information

Table 131. Shenyang Hongqi Pharmaceutical Description and Business Overview

Table 132. Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Product

Table 134. Shenyang Hongqi Pharmaceutical Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Enzalutamide Soft Capsules Distributors List

Table 138. Enzalutamide Soft Capsules Customers List

Table 139. Enzalutamide Soft Capsules Market Trends

Table 140. Enzalutamide Soft Capsules Market Drivers

Table 141. Enzalutamide Soft Capsules Market Challenges

Table 142. Enzalutamide Soft Capsules Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Enzalutamide Soft Capsules

Figure 2. Global Enzalutamide Soft Capsules Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Enzalutamide Soft Capsules Market Share by Type: 2024 & 2031

Figure 4. Original Drug Product Picture

Figure 5. Generic Drug Product Picture

Figure 6. Global Enzalutamide Soft Capsules Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Enzalutamide Soft Capsules Market Share by Application: 2024 & 2031

Figure 8. Hospital and Clinic

Figure 9. Retail Pharmacies

Figure 10. Other

Figure 11. Global Enzalutamide Soft Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Enzalutamide Soft Capsules Market Size (2020-2031) & (US$ Million)

Figure 13. Global Enzalutamide Soft Capsules Sales (2020-2031) & (K Units)

Figure 14. Global Enzalutamide Soft Capsules Average Price (US$/Unit) & (2020-2031)

Figure 15. Enzalutamide Soft Capsules Report Years Considered

Figure 16. Enzalutamide Soft Capsules Sales Share by Manufacturers in 2024

Figure 17. Global Enzalutamide Soft Capsules Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Enzalutamide Soft Capsules Players: Market Share by Revenue in Enzalutamide Soft Capsules in 2024

Figure 19. Enzalutamide Soft Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Enzalutamide Soft Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Enzalutamide Soft Capsules Sales Market Share by Country (2020-2031)

Figure 22. North America Enzalutamide Soft Capsules Revenue Market Share by Country (2020-2031)

Figure 23. United States Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Enzalutamide Soft Capsules Sales Market Share by Country (2020-2031)

Figure 26. Europe Enzalutamide Soft Capsules Revenue Market Share by Country (2020-2031)

Figure 27. Germany Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Enzalutamide Soft Capsules Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Enzalutamide Soft Capsules Revenue Market Share by Region (2020-2031)

Figure 34. China Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Enzalutamide Soft Capsules Sales Market Share by Country (2020-2031)

Figure 42. Latin America Enzalutamide Soft Capsules Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Enzalutamide Soft Capsules Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Enzalutamide Soft Capsules Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Enzalutamide Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Enzalutamide Soft Capsules by Type (2020-2031)

Figure 53. Global Revenue Market Share of Enzalutamide Soft Capsules by Type (2020-2031)

Figure 54. Global Enzalutamide Soft Capsules Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Enzalutamide Soft Capsules by Application (2020-2031)

Figure 56. Global Revenue Market Share of Enzalutamide Soft Capsules by Application (2020-2031)

Figure 57. Global Enzalutamide Soft Capsules Price (US$/Unit) by Application (2020-2031)

Figure 58. Enzalutamide Soft Capsules Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions